Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05647824 · ClinicalTrials.gov registry record
User Performance of the TV4 BGMS
A clinical trial, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- 402
- Enrollment target
NCT05647824: Completed study, sponsored by Ascensia Diabetes Care.
NCT05647824 is a clinical trial that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 402 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05647824 has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- 402 participants
- Enrollment target
Study Summary
Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).
Primary Outcome
Number of glucose results falling within ±15mg/dL of laboratory method at glucose concentration \<100 mg/dL and within ±15% at glucose concentrations ≥100 mg/dL
Interventions
- DEVICE Capillary Testing
- DEVICE Alternative Site Testing (AST)
- DEVICE Venous Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2020-07-23 |
What the finished NCT05647824 record still lists
NCT05647824 is an observational study that tracks outcomes without assigning an intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Capillary Testing is the first listed.
NCT05647824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05647824 about?
NCT05647824 is a clinical study titled "User Performance of the TV4 BGMS". Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also ...
What is the current status of trial NCT05647824?
This trial is currently completed. The enrollment target is 402 participants. The study started on 2020-02-05. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT05647824?
The interventions under investigation include: Capillary Testing (DEVICE), Alternative Site Testing (AST) (DEVICE), Venous Testing (DEVICE).
Who is sponsoring clinical trial NCT05647824?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI